Jinqiao Zhu
Founder @ EFung Capital
Jinqiao Zhu is a seed investor at EFung Capital focused on Medical and Health Care. Jinqiao Zhu is the founder of EFung Capital.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jinqiao Zhu invests in
Stages Jinqiao Zhu invests in
Countries Jinqiao Zhu invests in
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Huayuan Regenerative Medicine
|
Huayuan Regenerative Medicine is a developer of implantable biological artificial organs. | Seed / Feb 08, 2023 | |
Raynovent
|
Raynovent is a science-driven innovative biotech company. | $53.6M / Series C / Dec 30, 2022 |
Co-Investors
Guangdong Zhongsheng Pharmaceutical
1 deal together
HSG
1 deal together
Lake Bleu Capital
1 deal together
HSG
1 deal together
About EFung Capital
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
EFung Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jinqiao Zhu
Founder
|
|||
|
Luo Fayong
Managing Director
|
|||
|
Pai Zhu
Managing Partner
|
|||
Yu Wang
Chief Scientist
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jinqiao Zhu invest in?
Jinqiao Zhu invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jinqiao Zhu last invest?
The most recent investment recorded for Jinqiao Zhu closed in Feb 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
